Symptom Experiences and Quality of Life in Adolescents with Cancer Receiving Cancer Treatments

Main Article Content

Donruedee Kamkhoad, RN
Autchareeya Patoomwan, RN, PhD
Samart Pakakasam, MD


OBJECTIVES: This descriptive correlational study aimed to explore symptom experiences, quality of life (QOL), and the relationship between these variables in adolescents with cancer receiving treatments.

MATERIAL AND METHODS: 25 adolescents, recruited from a university hospital, Thailand, diagnosed with various types of cancer; age 10-15 years; having received at least one cycle of chemotherapy. The participants reported their symptom experiences, using MSAS (10-18) and their QOL, using the pediatrics quality of life (PedsQL) 4.0. Descriptive statistics and Pearson’s product-moment correlational coefficient were used to describe the results.

RESULT: Most of the participants were male (68%), with a mean age of 12.74 ± 20.44 years, and were diagnosed with hematological cancers (56%). They experienced a mean of 11.80 ± 5.61 symptoms. Dry mouth was found to be the most common and frequent symptom; swelling at arms or legs was rated as the most severe, and changes in the way food tastes was the most distressing symptom. All dimensions of symptom experiences had significant negative correlations with overall QOL (p < 0.05).

CONCLUSION: Symptom experiences and QOL among adolescent cancer patients after chemotherapy showed specific differences. Therefore, nurses should assess every aspect for both inpatient and outpatient departments, thereby leading to improved QOL.


Download data is not yet available.

Article Details

How to Cite
Kamkhoad D, Patoomwan A, Pakakasam S. Symptom Experiences and Quality of Life in Adolescents with Cancer Receiving Cancer Treatments. BKK Med J [Internet]. 2019 Sep. 20 [cited 2023 Nov. 30];15(2):173. Available from:
Original Article


1. Imsamran W, Chaiwarawattana A, Wiangnon S, et al. Cancerin Thailand. In: Cancer Registry Unit NCIT, editor. Bangkok,Thailand: New Thammada Press (Thailand) Co., Ltd., 2015.
2. Ramathibodi Cancer Registry. Ramathibodi Cancer Report2015, 2015. (Accessed June 24, 2018, at [in Thai].
3. Ramathibodi Cancer Registry. Ramathibodi Cancer Report2016, 2016. (Accessed June 24, 2018, at report/pdf/cancer_report_2016_0.pdf [in Thai].
4. National Cancer Institute & LIVESTRONG Young AdultAlliance. Closing the gap: Research and care imperatives foradolescents and young adults with cancer, 2006. (AccessedFebruary 2, 2019, at
5. Williams PD, Williams AR, Kelly KP, et al. A symptomchecklist for children with cancer: Therapy-Related SymptomChecklist-Children. Cancer Nurs 2012;35(2):89-98.
6. Li HC, Williams PD, Lopez V, et al. Relationships amongtherapy-related symptoms, depressive symptoms, and qualityof life in Chinese children hospitalized with cancer: anexploratory study. Cancer Nurs 2013;36(5):346-54.
7. Baggott CR, Dodd M, Kennedy C, et al. An evaluation of thefactors that affect the health-related quality of life of childrenfollowing myelosuppressive chemotherapy. Support CareCancer 2011;19(3):353-61.
8. Hinds PS, Billups CA, Cao X, et al. Health-related quality oflife in adolescents at the time of diagnosis with osteosarcomaor acute myeloid leukemia. Eur J Oncol Nurs 2009;13(3):156-63.
9. Hinds PS, Gattuso JS, Fletcher A, et al. Quality of life asconveyed by pediatric patients with cancer. Qual Life Res2004;13(4):761-72.
10. Zola IK. Culture and symptoms--an analysis of patient’spresenting complaints. Am Sociol Rev 1966;31(5):615-30.
11. Williams PD, Piamjariyakul U, Shanberg R, et al. Monitoringand alleviation of symptom occurrence and severity amongThai children and adolescents during cancer treatments.J Pediatr Oncol Nurs 2015;32(6):417-28.
12. Pongsing Y. Thai mothers’ reports of symptoms in youngchildren receiving chemotherapy [Dissertation]: OregonHealth & Science University; 2010.
13. Lenz ER, Pugh LC, Milligan RA, et al. The middle-rangetheory of unpleasant symptoms: an update. Adv Nurs Sci1997;19(3):14-27.
14. Hegyvary ST. Patient care outcomes related to managementof symptoms. Annual Rev Nurs Res 1993;11:145-68.
15. Collins JJ, Byrnes ME, Dunkel IJ, et al. The measurement ofsymptoms in children with cancer. J Pain Symptom Manag2000;19(5):363-77.
16. Varni JW, Burwinkle TM, Katz ER, et al. The PedsQL inpediatric cancer: reliability and validity of the PediatricQuality of Life Inventory Generic Core Scales, MultidimensionalFatigue Scale, and Cancer Module. Cancer 2002;94(7):2090-106.
17. Sritipsukho P, Wisai M, Thavorncharoensap M. Reliabilityand validity of the Thai version of the Pediatric Quality ofLife Inventory 4.0. Qual Life Res 2013;22(3):551-7.
18. El-Housseiny AA, Saleh SM, El-Masry AA, et al. Assessmentof oral complications in children receiving chemotherapy.J Clin Pediatr Dent 2007;31(4):267-73.
19. Herring RA, Hesselgrave J, Norville R, et al. Toxicity andsymptom management: Kline NE, editor. The PediatricChemotherapy and Biotherapy Curriculum. 3 ed. IL:Association of Pediatric Hematology/Oncology Nurses,2011:105-51.
20. Ritchie MA. Psychosocial nursing care for adolescents withcancer. Issues Compr Pediatr Nurs 2001;24(3):165-75.
21. Af Sandeberg M, Johansson E, Bjork O, et al. Health-relatedquality of life relates to school attendance in children ontreatment for cancer. J Pediatr Oncol Nurs 2008;25(5):265-74.